Your browser is no longer supported. Please, upgrade your browser.
Settings
NBY NovaBay Pharmaceuticals, Inc. daily Stock Chart
NBY [NYSE]
NovaBay Pharmaceuticals, Inc.
Index- P/E2.17 EPS (ttm)0.55 Insider Own25.78% Shs Outstand17.83M Perf Week-4.81%
Market Cap21.39M Forward P/E- EPS next Y-0.35 Insider Trans0.00% Shs Float5.15M Perf Month8.05%
Income8.10M PEG- EPS next Q-0.07 Inst Own1.00% Short Float1.01% Perf Quarter-7.74%
Sales15.20M P/S1.41 EPS this Y124.00% Inst Trans3.48% Short Ratio2.25 Perf Half Y-57.16%
Book/sh0.35 P/B3.43 EPS next Y- ROA-39.00% Target Price2.75 Perf Year-67.58%
Cash/sh0.29 P/C4.11 EPS next 5Y- ROE-71.90% 52W Range0.97 - 4.20 Perf YTD-68.85%
Dividend- P/FCF- EPS past 5Y15.50% ROI201.00% 52W High-71.44% Beta-0.67
Dividend %- Quick Ratio2.70 Sales past 5Y21.30% Gross Margin86.60% 52W Low24.17% ATR0.15
Employees86 Current Ratio2.80 Sales Q/Q-24.40% Oper. Margin-39.30% RSI (14)47.97 Volatility17.72% 10.83%
OptionableNo Debt/Eq0.00 EPS Q/Q43.60% Profit Margin-29.50% Rel Volume0.36 Prev Close1.20
ShortableYes LT Debt/Eq0.00 EarningsNov 14 AMC Payout- Avg Volume23.09K Price1.20
Recom2.30 SMA202.14% SMA50-12.19% SMA200-48.02% Volume8,288 Change-0.05%
Jul-06-18Reiterated H.C. Wainwright Buy $4
Nov-15-17Reiterated Laidlaw Buy $10 → $8
Jun-05-17Initiated ROTH Capital Buy $5.50
Mar-27-17Initiated Laidlaw Buy $10
Feb-06-17Initiated Rodman & Renshaw Buy $6
Mar-07-16Downgrade Maxim Group Buy → Hold
Dec-14-15Reiterated Maxim Group Buy $1 → $0.23
Apr-30-15Resumed Maxim Group Buy $2
Mar-06-13Initiated Ascendiant Capital Markets Strong Buy $2.25
Jan-03-08Initiated Dawson James Speculative Buy $8
Nov-14-18 04:05PM  NovaBay Pharmaceuticals Reports Third Quarter 2018 Financial Results Business Wire
Nov-07-18 06:50AM  NovaBay Pharmaceuticals to Hold Third Quarter 2018 Conference Call on November 14, 2018 Business Wire
Nov-06-18 10:30AM  Will NovaBay Pharmaceuticals (NBY) Report Negative Earnings Next Week? What You Should Know Zacks
Sep-28-18 06:50AM  NovaBay Pharmaceuticals Names Jack McGovern Interim CEO Business Wire
Aug-30-18 08:00AM  NovaBay Pharmaceuticals to Present at H.C. Wainwright 20th Annual Global Investment Conference on September 6 Business Wire +8.82%
Aug-07-18 04:05PM  NovaBay Pharmaceuticals Reports Second Quarter 2018 Financial Results Business Wire
02:30PM  NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 06:50AM  NovaBay Pharmaceuticals to Hold Second Quarter 2018 Conference Call on August 7, 2018 Business Wire +8.89%
Jul-05-18 06:50AM  NovaBay Pharmaceuticals Expands Sales Organization to Re-energize Growth Business Wire
May-10-18 04:05PM  NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results Business Wire
May-07-18 06:50AM  NovaBay Pharmaceuticals to Hold First Quarter 2018 Conference Call on May 10, 2018 Business Wire
Mar-20-18 04:05PM  NovaBay Pharmaceuticals Reports 2017 Fourth Quarter and Full Year Financial Results Business Wire
12:00PM  NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
07:41AM  NovaBay Pharmaceuticals Q4 Earnings Outlook Benzinga
Mar-01-18 10:49PM  BRIEF-Jinzi Ham's Unit Scraps Plan To Invest In Novabay Pharma, To Boost Asset Management Subsidiary's Capital Reuters
03:53AM  BRIEF-Jinzi Ham's Unit Scraps Plan To Invest In Novabay Pharma, To Boost Asset Management Subsidiary's Capital Reuters
Feb-21-18 06:50AM  NovaBay Pharmaceuticals to Hold 2017 Fourth Quarter and Full Year Conference Call on March 20, 2018 Business Wire
Feb-12-18 06:50AM  NovaBay Pharmaceuticals Completes $6.0 Million Private Placement Business Wire
Jan-08-18 06:50AM  NovaBay Pharmaceuticals Announces Preliminary Sales for 2017 Fourth Quarter and Full Year Business Wire
Dec-22-17 06:50AM  NovaBay Pharmaceuticals Receives Stockholder Approval for Proposed $10.32 Million Financing Agreement Business Wire
Dec-21-17 06:50AM  NovaBay Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards Business Wire +5.43%
Dec-19-17 01:41PM  ETFs with exposure to NovaBay Pharmaceuticals, Inc. : December 19, 2017 Capital Cube
Dec-06-17 06:50AM  NovaBay Pharmaceuticals Names Lewis J. Stuart Chief Commercial Officer Business Wire -5.13%
Nov-30-17 02:09PM  ETFs with exposure to NovaBay Pharmaceuticals, Inc. : November 30, 2017 Capital Cube
Nov-29-17 08:02AM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-14-17 04:05PM  NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results Business Wire +6.08%
11:00AM  NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
05:01AM  BRIEF-Jinzi Ham's unit to invest in Novabay Pharma and become its biggest shareholder Reuters
Nov-07-17 06:50AM  NovaBay Pharmaceuticals to Hold Third Quarter 2017 Conference Call on November 14 Business Wire
Sep-26-17 09:00AM  Dry Eye Advances from NovaBay and Johnson & Johnson Vision's TearScience ACCESSWIRE
Sep-20-17 06:50AM  NovaBay Pharmaceuticals Receives Notification of Noncompliance with Additional NYSE American Continued Listing Standards Business Wire
Sep-19-17 06:10PM  ETFs with exposure to NovaBay Pharmaceuticals, Inc. : September 19, 2017 Capital Cube
Sep-18-17 12:01PM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017 Capital Cube +8.75%
09:00AM  Eye Surgeon Says Keep Eyelids Healthy with Avenova from NovaBay ACCESSWIRE
Sep-05-17 06:50AM  NovaBay Pharmaceuticals to Present at Rodman & Renshaw 19th Annual Global Investment Conference Business Wire
Aug-14-17 09:00AM  NovaBay's Avenova Offers Key Benefits in Glaucoma Care ACCESSWIRE
Aug-10-17 04:05PM  NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results Business Wire +8.24%
02:00PM  Investor Network: NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 06:50AM  NovaBay Pharmaceuticals to Hold 2017 Second Quarter Conference Call on August 10, 2017 Business Wire
Jul-24-17 10:00AM  Fighting Parasitic Eyelid Mites with Avenova from NovaBay Pharmaceuticals Accesswire
Jul-10-17 01:32PM  UPDATE: NovaBay's Avenova Highlighted in National Dry Eye Awareness Month Accesswire
10:00AM  NovaBay's Avenova Highlighted in National Dry Eye Awareness Month Accesswire
06:50AM  NovaBay Pharmaceuticals Announces CFO Transition Business Wire
Jun-26-17 06:50AM  NovaBay Pharmaceuticals Joins the Russell Microcap Index Business Wire +8.45%
Jun-13-17 10:14AM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017 Capital Cube
May-30-17 06:50AM  NovaBay Pharmaceuticals to Present at the 7th Annual LD Micro Invitational Business Wire
May-19-17 04:05PM  NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE MKT Business Wire
May-11-17 04:05PM  NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results Business Wire
May-04-17 06:50AM  NovaBay Pharmaceuticals to Hold 2017 First Quarter Conference Call on May 11, 2017 Business Wire
May-02-17 10:00AM  Avenova from NovaBay Pharmaceuticals is Effective for Managing Dry Eye before Refractive and Cataract Eye Surgery Accesswire
Apr-17-17 10:00AM  NovaBay's intelli-Case Can Safely and Effectively Disinfect Contact Lenses, CEOCFO Magazine Reports Accesswire
Mar-29-17 01:04PM  NOVABAY PHARMACEUTICALS, INC. Financials
Mar-28-17 12:47PM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017 Capital Cube
12:47PM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017
10:33AM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: 2016 By the Numbers : March 28, 2017
10:00AM  Avenova from NovaBay Pharmaceuticals Effective for Painful Eye Condition Accesswire
Mar-27-17 08:57AM  Coverage initiated on NovaBay Pharma by Laidlaw
Mar-24-17 10:50AM  Edited Transcript of NBY earnings conference call or presentation 23-Mar-17 8:30pm GMT Thomson Reuters StreetEvents
Mar-23-17 04:14PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
04:05PM  NovaBay Pharmaceuticals Reports 2016 Full Year and Fourth Quarter Financial Results and Provides 2017 Financial Guidance Business Wire
07:07AM  Q4 2016 NovaBay Pharmaceuticals Inc Earnings Release - After Market Close
Mar-16-17 06:50AM  NovaBay Pharmaceuticals to Hold 2016 Fourth Quarter and Full Year Conference Call on March 23, 2017 Business Wire
Mar-09-17 06:50AM  NovaBay Pharmaceuticals to Present Features and Benefits of the intelli-Case at FDA Public Advisory Meeting Business Wire
Mar-08-17 10:00AM  Explaining Innovative Drug Technologies Through Animation Accesswire
Mar-07-17 06:50AM  NovaBay Pharmaceuticals to Present at 29th Annual ROTH Conference Business Wire
Feb-14-17 10:00AM  Relief from Painful Dry Eye Can be a Real Valentine's Day Gift Accesswire
Jan-30-17 10:00AM  NovaBay CEO Sees Continued Double-Digit Revenue Growth in 2017 Accesswire
Jan-27-17 10:00AM  NovaBay Pharmaceuticals' "Avenova" Helping Patients with Contact Lens Intolerance Accesswire +5.63%
Jan-09-17 06:50AM  NovaBay Pharmaceuticals Announces Preliminary Sales for the Fourth Quarter of 2016 Business Wire +12.12%
Dec-19-16 10:00AM  NovaBay's Avenova Brings Quick Relief to Children Suffering from Eye Conditions, Writes Steven J. Lichtenstein, M.D. Marketwired
06:05AM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
Dec-01-16 06:50AM  NovaBay to Present at LD Micro Main Event Business Wire
Nov-29-16 11:17AM  MULTIMEDIA UPDATE - NovaBay's Avenova Is Breakthrough in Fight Against Contact Lens Intolerance Marketwired
10:00AM  NovaBay's Avenova Is Breakthrough in Fight Against Contact Lens Intolerance Marketwired
Nov-23-16 10:59AM  Five Stocks Under $5.00 for December (NAK, GGB) at Investopedia
Nov-14-16 11:40AM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
Nov-10-16 04:17PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results Business Wire
Nov-03-16 06:50AM  NovaBay Pharmaceuticals to Hold Third Quarter 2016 Conference Call on November 10 Business Wire
Oct-31-16 05:05PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:50AM  NovaBay Pharmaceuticals Successfully Regains Compliance with NYSE Continued Listing Requirements Business Wire
Oct-24-16 08:01AM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
Oct-11-16 09:45AM  Eyelid Hygiene Cleanser Called "Avenova(R) with Neutrox(R)" Offers Help for Tired, Aging Eyes Accesswire
Oct-03-16 06:50AM  NovaBay Pharmaceuticals Receives $7 Million from Early Warrant Exercise Business Wire
Sep-30-16 04:31PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
Sep-23-16 03:11PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of NovaBay Pharmaceuticals, Inc. - NBY Accesswire
Sep-19-16 12:28PM  TerraForm Power Inc (TERP) and Three Other Stocks Trading Higher on Positive News; Community Health Systems (CYH) Plunges at Insider Monkey
09:50AM  New Therapy Introduced for Chronic Dry Eye Accesswire
06:50AM  NovaBay Pharmaceuticals Auriclosene® Demonstrates Statistically Significant and Clinically Meaningful Results in Phase 2b Study for the Prevention of Urinary Catheter Blockage and Encrustation Business Wire
Sep-12-16 06:50AM  NovaBay Pharmaceuticals Neutrox® Product Line Receives CE Mark and ISO Certification for the European Union Business Wire
Sep-06-16 06:50AM  NovaBay Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference Business Wire
Aug-26-16 04:32PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
Aug-25-16 04:31PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
Aug-15-16 10:00AM  Dry Eye: A Growing Problem in an Aging Population Accesswire
Aug-12-16 11:38AM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 04:14PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  NovaBay Pharmaceuticals Reports 2016 Second Quarter Financial Results Business Wire
Aug-04-16 06:50AM  NovaBay Pharmaceuticals to Hold Second Quarter 2016 Conference Call on August 11 Business Wire
Aug-02-16 04:31PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:50AM  NovaBay Pharmaceuticals Completes $11.8 Million Private Placement Business Wire
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic and anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.